Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131897) titled 'The Era of Targeted Immunotherapy: Timing of Radiotherapy and Interventional Therapy in Patients with Primary Liver Cancer and Portal Vein Cancer Thrombus: A Prospective Cohort Study' on Sept. 7.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Hospital of Jilin University

Condition: Primary liver cancer with portal vein tumor thrombus

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-15

Target Sample Size: Early radiotherapy group and late radiotherapy group:110;

Countries of Recruitment: China

To know more, visit https://www.chic...